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INTRODUCTION 
 Laparoscopic surgery is a technique with cosmetic advantage, 
reduction of hospital days, postoperative pain and morbidity. However  
laparoscopy also induces certain pathophysiological  hemodynamic changes in 
response to pneumoperitoneum ,which include an increase in mean arterial 
pressure, decrease in cardiac output and increase in systemic vascular 
resistance. Treating patients with clonidine blunted the increase in mean arterial 
pressure, systemic vascular resistance and the release of catecholamines. (1) 
Considering this, the present study was designed to evaluate the type and extent 
of haemodynamic changes associated with laparoscopic surgery and  to find out 
the efficacy of clonidine in prevention of such changes. The results of the study 
can promote further evaluation and usage of  the drug for laproscopy in patients 
with compromised cardiovascular system. 
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AIM OF THE STUDY 
To evaluate the efficacy of oral clonidine premedication in blunting 
hemodynamic response to pneumoperitoneum in laproscopic surgeries. 
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THE HEMODYNAMIC RESPONSE TO PNEUMOPERITONEUM 
 Laparoscopy is endoscopic visualization of the peritoneal cavity 
usually assisted by a pneumoperitoneum that distends and separates the 
abdominal wall from its contents. CO2 gas insufflation is preferred by most 
laparoscopists because it has a high diffusion coefficient and is a normal 
metabolic end product rapidly cleared from the body. Also, CO2 is highly 
soluble in blood and tissues and does not support combustion. 
The cardiovascular system is one of the most challenged systems of the 
human body during laparoscopy. Changes occurring during CO2 
pneumoperitoneum result from two main factors:   
• Hypercarbia (and the subsequent acidosis)  
• Increased intra-abdominal pressure.  
 CO2 is highly soluble and therefore is very rapidly absorbed from the 
peritoneal cavity into circulation. Because absorbed CO2 can only be excreted 
through the lungs, hypercarbia can only be avoided by a compensatory 
hyperventilation by increasing the tidal volume of ventilation in anesthetized 
patients. Hypercarbia can also develop as a result of  an insufficiently 
exhaustion of CO2. Absorption of CO2 is increased particularly during 
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prolonged surgery using high intra-abdominal pressure. Exhaustion of CO2 is 
reduced in patients with compromised cardiopulmonary function and restricted 
CO2 clearance . Also, the compensatory hyperventilation is impeded by the 
Trendelenburg position or a high intraabdominal pressure, which cause a 
cephalad displacement of the diaphragm (resulting in reduction of lung 
volumes) and a restriction in diaphragmatic mobility. In these conditions, severe 
hypercarbia can develop despite aggressive hyperventilation.  
 Hypercarbia and acidosis can cause hemodynamic changes by direct 
action on the cardiovascular system and by an indirect action through 
sympathoadrenal stimulation. The direct effect of carbon dioxide and acidosis 
can lead to decreased cardiac contractility, sensitization  of myocardium to the 
arrhythmogenic effects of catecholamines  and systemic vasodilatation. The 
centrally mediated, autonomic effects of hypercarbia  lead to a widespread 
sympathetic stimulation resulting in tachycardia and vasoconstriction. 
  It should be stressed that intra-abdominal pressure has a major role 
in the development of hypercarbia since it both increases the absorption and 
decreases the exhaustion of CO2. Increased intra-abdominal pressure during 
pneumoperitoneum triggers several pathophysiological   mechanisms  
independently   of  the  type  of  used gas. The most important mechanism is  
neurohumoral . Humoral response  causes  release of  vasopressin and activation 
5 
 
of renin-angiotensin-aldosterone. The sympathetic stress response(neural) , 
causes tachycardia and hypertension. The increased intra-abdominal pressure 
also leads to a mechanical impairment of the venous return thus decreasing the 
cardiac preload. Depending on the extent of above mentioned mechanisms there 
will be an increase in systemic vascular resistance and pulmonary vascular 
resistance resulting in an increased afterload and the final outcome depends on 
the functional reserve of the heart. 
 Joris et al 5, using invasive monitoring, observed a significant increase in 
mean arterial pressure (35%) after peritoneal insufflations, along with an 
increase of systemic vascular resistance (65%) and pulmonary vascular 
resistance (90%), and a decrease in cardiac index (20%), while the pulmonary 
capillary wedge pressure and central venous pressure increased.  
The measures suggested to prevent and treat the cardiovascular 
complications are  
• Preloading with about 10ml/kg of crystalloid, to improve the 
cardiac preload. 
• Intermittent pneumatic compression of lower limbs, to increase 
venous return and preload. 
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• Avoiding extreme positioning, as it affects both cardiac preload 
and ventilation. 
• Slow insufflation. 
• Maintaining lower intra-abdominal pressures. 
• Maintaining normocarbia. 
• Tilting the patient after insufflation.   
• Pharmacological therapy   ( α-2 agonists, β- blockers, vasodilators, 
remifentanyl etc)    
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PHARMACOLOGY OF CLONIDINE 
 
Clonidine Hydrochloride is an imidazoline derivative and exists as a 
mesomeric compound. The chemical name is 2-(2,6-dichlorophenylamino)-2-
imidazoline hydrochloride. The following is the structural formula: 
 Pharmacodynamics: 
    Clonidine produces clinical effects after binding to α2-adrenergic 
receptors, of which there are three subtypes (α 2A, α2B, and α2C). Because  of  
an imidazole ring in its structure, this compound  also interacts  with the 
imidazoline receptor. Clonidine can produce either hypotension or hypertension. 
At lower doses, the dominant action  is sympatholysis, i.e., the ability to block 
the sympathetic arm of the autonomic nervous system, which is mediated by the 
α 2A-adrenergic receptor subtype. At higher doses, the hypertensive action 
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dominates via the activation of α2B adrenoceptors, located on smooth muscle 
cells in the resistance vessels. 
In the heart, the dominant action  is a decrease in tachycardia (through 
block of the cardioaccelerator nerve) and bradycardia (through a vagomimetic 
action). 
On the central nervous system, it excerts following actions- sedation, 
hypnosis, analgesia, anxiolysis, cognitive enhancement etc.. 
Pharmacokinetics: 
 Oral clonidine is well absorbed and used completely in the body. 
The pharmacological effect of clonidine appears in  about 1.5 hours, with the 
peak level in 3 hours. The patient's blood pressure declines within 30 to 60 
minutes after an oral dose, the maximum decrease occurring within 2 to 4 hours. 
The half life is approximately 8.5±0.9hours. Renal blood flow and glomerular 
filtration rate remain essentially unchanged. Normal postural reflexes are intact; 
therefore, orthostatic symptoms are mild and infrequent. . Neither food nor the 
race of the patient influences the pharmacokinetics of clonidine. 
Clonidine is highly lipid soluble and easily crosses the blood brain 
barrier, interacting with alpha-adrenergic receptors at the spinal and supraspinal 
9 
 
sites. Following oral administration about 40-60% of the absorbed dose is 
recovered in the urine as unchanged drug in 24 hours. In patients with renal 
impairment half-life can increase upto 41 hours. About 50% of the absorbed 
dose is metabolized in the liver. 
USES: 
Clonidine, was first introduced into clinical practice (in the1970s), as an 
antihypertensive medication, which forms the bulk of its use, even now. The 
drug has also been used to treat dysmenorrhoea, hot flushes that occur with 
menopause, attention deficit hyperactivity disorder (ADHD), and withdrawal 
symptoms from dependence on narcotics, alcohol, or nicotine (smoking). 
It has found lot of use perioperatively. It  attenuates hypertension, 
tachycardia, and catecholamine release in response to stress induced by 
anaesthetic and surgical procedures,(e.g) Laryngoscopy,  peritoneal insufflation 
etc. The drug has been used for anaesthetic premedication, providing sedative, 
anxiolytic, and analgesic effects . It decreases the requirements for both IV and 
volatile anaesthetics. It also reduces post operative shivering, nausea and 
vomiting. It has also been proved to decrease perioperative myocardial 
ischaemia by reducing the myocardial work. Time for post operative analgesic 
requirement is prolonged and better sedation scores obtained with clonidine. 
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SIDE EFFECTS: 
 Most commonly reported side effect is dry mouth or xerostomia, 
followed by dizziness, drowsiness, constipation and sedation.  
Adverse effects have been reported as an extension of its pharmacologic 
profile (i.e., hypotension, bradycardia,  and hypertension). 
Other very rare side effects are paresthesia, abdominal pain, nausea, 
urticaria, urinary retention, erectile dysfunction, gyaenecomastia etc and they 
don’t occur with a single dose given preoperatively. 
DRUG INTERACTIONS: 
Clonidine may potentiate the CNS-depressive effects of alcohol, 
barbiturates or other sedating drugs.  
If a patient receiving clonidine hydrochloride is also taking tricyclic 
antidepressants, the hypotensive effect of clonidine may be reduced, 
necessitating an increase in the clonidine dose.          
Clonidine when used  concomitantly with agents known to affect sinus 
node function or AV nodal conduction, e.g., digitalis, calcium channel blockers, 
and beta-blockers, Sinus bradycardia can occur.  
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CONTRAINDICATIONS: 
The only absolute contraindication is allergy to the drug. 
Clonidine should be used with caution in patients with  
• Severe coronary insufficiency 
• Conduction disturbances  
• Recent myocardial infarction  
• Cerebrovascular disease or chronic renal failure.  
 
It is also not used in pregnant, lactating and paediatric population. 
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MATERIALS AND METHODS 
  
This interventional study was done in fifty patients undergoing elective 
laproscopic surgery either appendicectomy or cholecystectomy under general 
anaesthesia. It is a prospective randomised single blinded study. 
 Institutonal ethical committee approval was obtained and written 
informed consent was obtained from all patients. The study was conducted 
during the period from may 2010 to july 2010, in the Institute of 
Anaesthesiology and Critical care, Govt General Hospital, Chennai. The 
surgeries were done in general surgery theatre complex of the hospital. 
INCLUSION CRITERIA: 
• Patients of both sexes. 
• ASA Physical Status 1-2.  
• Age 16- 65 years.  
EXCLUSION CRITERIA 
• Diabetics  
• Hypertensives 
• Patients with Ischaemic Heart Disease  
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• COPD patients/ Asthmatics 
• Patients  with known allergy to drugs used in the study. 
• Patients with difficult airway. 
• Patients on concomitant drugs like MAO inhibitors, methyl 
dopa, benzodiazipines,beta blockers etc. 
• Patients with increased intracranial tension/ 
•  Patients with renal impairment. 
• Those with A-V block and severe valvular insufficiencies. 
 
MATERIALS: 
• Oral Clonidine  150µg tablets / Plecebo- Multi Vitamin 
tablets 
• Routine Anaesthetic Equipments 
• Drugs-Inj.Fentanyl,  Inj.Ranitidine, Inj.Metaclopromide, 
Inj.Propofol, Inj.suxamethonium, Inj. Vecuronium, 
Inj.Neostigmine, Inj. Glycopyrrolate, IV Fluids and 
Emergency drugs. 
• Monitors – ECG, SPO2, NIBP , ETCO2 , intra-abdominal   
pressure. 
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METHOD:  
  All patients underwent minimum investigations – haemoglobin, renal 
function tests, chest X-ray and electrocardiogram. Pre-operative assessment was 
done for all patients in Central anaeathesic Assessment Room(CAR). Patients 
belonging to ASA physical status 1 or 2 were only selected for the study. 
  Patients selected for the study were randomized into two groups- 
Group P( placebo) and Group C (Clonidine) 
 On the morning of surgery,  patients were given either oral 
clonidine 150µg tablet ( Group C) or Multivitamin tablet (Group P)  with about 
30 to 60 ml of clear water. Before the intake of study drug baseline heart rate, 
systolic, diastolic, and mean arterial pressures were measured. Patients were 
shifted to a calm room where they were observed. Intravenous access was 
obtained and they were preloaded with 10 ml/kg of Ringer Lactate solution. 
          About 90 minutes after that they were shifted to the operating table. 
The monitors used were, Electrocardiograph, Pulse oximetry, blood pressure by 
automated oscillometry. After intubation, End Tidal CO2 and after induction of 
pneumoperitoneum, intra abdominal pressure was monitored. The drugs used 
and anaesthetic technique was standardized for both groups. 
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Premedication: 
• Inj.Ranitidine 50mg and Inj.Metaclopromide  10mg were given i.v 
to avoid post operative nausea and vomiting, which is very 
common in laproscopic surgeries. 
• Inj.fentanyl 2µg/kg i.v for analgesia  
• Inj. Glycopyrrolate 0.2mg i.v for antisecretory action.  
Preoxygenation: 
 Done for three minutes with 4 lit/min of 100% 02. 
Induction:   
 With 2mg/kg Inj. propofol and 1.5 mg/kg Inj. Succinyl choline 1.5 
mg/kg i.v 
Intubation: 
 Appropriate size laryngoscope blade and appropriate size cuffed 
endotracheal tube was used.  None of the patients had a predicted difficult 
airway and intubation in all patients was done in a single attempt with ease by 
the same investigator. Soon after the endotracheal tube was secured, a 
nasogastric tube was inserted and bladder was catherised for all patients. 
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Maintenance: 
 Nitrous oxide was used in a concentration of 66% with Oxygen 
33% . Inj. Propofol infusion at the rate of 3mg/kg/hr was used for maintenance 
of anaesthesia. It was started soon after induction and terminated at the time of 
desufflation of pneumoperitoneum. For muscle relaxation inj. Vecuronium 
0.1mg/kg i.v was given followed by 1mg i.v everytime the neuromuscular 
action recovered. Intra operative hydration was maintained with Ringer Lactate. 
 Ventilation was done such that all patients had ETCO2 between 
35-40 mmHg throughout the procedure. 
Surgical procedure: 
 The selected patients underwent either appendicectomy or 
cholecystectomy by laproscopy. After induction and intubation bladder was 
catheterised and then abdomen painted and draped. Pneumoperitoneum was 
created  with insufflations of CO2 through Verre’s needle in the supraumbilical 
region following which the surgery was proceeded with. The intra- abdominal 
pressure was strictly below 14 mmHg and was maintained between 12- 
14mmHg. The average duration of  surgery  was 54.34 min  for appendicectomy 
and 90.46 min  for cholecystectomy. 
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Reversal and extubation: 
 At the end of surgery, neuromuscular blockade was reversed with 
50µg/kg of Inj. Neostigmine and 0.2 mg of Inj.glycopyrrolate for every mg of 
neostigmine. Patients were extubated after recovery of airway reflexes and 
consciousness and thorough oral suctioning. Patients were shifted to recovery 
room, given supplemental Oxygen via mask and observed for two hours after 
which patients were shifted to post-operative ward. 
Outcome measures: 
 Through the surgery, the study outcome measures (i.e) the 
haemodynamic variables – heart rate, systolic, diastolic, and mean arterial 
pressures were noted at these times - 
1. On table- before induction. 
2. Just after intubation 
3. 5 min after intubation 
4. 5 min after insufflation 
5. 15 min after insufflation 
6. 30 min after insufflation 
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7. After  extubation 
 The incidence of complications  in hemodynamic parameters,  
(hypotension, bradycardia, hypertension), and the need for treatment was also 
noted in both groups. They were defined and treated as follows; 
 A mean arterial pressure of less than 60mmHg was considered 
hypotension and was treated with  i.v bolus of 6 mg ephedrine, which was 
repeated  as needed. 
 A heart rate of less than 50 beats/ min was considered as 
bradycardia  and was treated with 0.6mg i.v bolus of  Atropine.  
 A mean arterial pressure of more than 120mmHg lasting more than 
five minutes  was treated with intravenous infusion of nitroglycerin 5µg/kg/hr. 
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REVIEW OF LITERATURE 
 In a study by Y.Passi et al(2009) fifty adult patients belonging to 
ASA physical status I or II, scheduled for laparoscopic Cholecystectomy were 
randomly allocated to two groups . Group A (clonidine) received Tab. clonidine 
150μg orally and Group B (Control) received Tab. vitamin B complex orally as 
premedication 60-90 minutes before scheduled laparoscopy. Heart rate and 
mean blood pressure were recorded prior to intubation, 15 min after 
endotracheal intubation, at skin incision, 15 min and 30 min after creation of 
pneumoperitoneum and 15 min after release of pneumoperitoneum. Anaesthetic 
technique was standardized , normocapnia and safe intra abdominal pressure 
(12-14 mmHg) maintained. Heart rate and mean arterial pressure was 
significantly low in the clonidine group at all instances except prior to 
intubation. One patient each developed bradycardia and hypotension in Group 
A which was managed with Inj.Atropine 0.5 mg and Inj. Ephedrine 6mg 
boluses respectively. Hypertension occurred in 9 patients in the group B  and 
was managed with increase in concentration of Isoflurane and antihypertensive 
drugs e.g. Inj. NTG or Inj. esmolol as infusion i.v.  They concluded that oral 
clonidine 150 μg 60- 90 min before scheduled laparoscopic cholecystectomy 
provides stable hemodynamics and protection against stress response triggered 
by pneumoperitoneum. 
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 M. Das et al did a similar study in Indian population in 2007.Sixty 
adult patients of ASA physical status I & II, scheduled for elective laparoscopic 
cholecystectomy were randomly allocated to one of the two groups to receive 
either oral clonidine 150 µg (Group C) or ranitidine 150 mg (Group P), 90 
minute before induction of anaesthesia. Anaesthetic technique and intra 
abdominal pressure were standardized. Systemic arterial pressure including the 
systolic, diastolic and mean arterial pressure, heart rate were recorded at the 
following points of time : (1) prior to induction (2) three minutes after 
endotracheal intubation (3) before pneumoperitoneum (4) fifteen minutes after 
pneumoperitoneum (5) thirty minutes after pneumoperitoneum(6) ten minutes 
after release of CO2 and (7) ten minutes after extubation. Significant rise in 
heart rate was observed following pneumoperitoneum in control as compared to  
Clonidine group.(99.23±14.02 Vs 81.26±8.40 bpm). Similarly, rise in systolic 
arterial pressure(143.63±19.60 Vs 119.6±10.06mm Hg), diastolic arterial 
pressure (99.23±14.02 Vs81.26±8.40 mm Hg) and mean arterial pressure 
(114.13±16.57 Vs 93.83±8.107 mm Hg) was more in control group following 
pneumoperitoneum. Ten patients (33.3%) in placebo group received 
nitroglycerine infusion (0.5 µg.kg-1 .min-1) for treatment of intraoperative 
hypertension. It was not required in the clonidine group. 
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Sunita Goel and Manju Sinha from Bombay Hospital(2006) conducted a 
similar study. They gave 100 µg oral clonidine as premedication one hour 
before major laproscopic  gyaenecologic surgeries in 50 patients and compared 
it with placebo in another 50 patients. They compared the hemodynamic 
variables at induction, intubation, 5 min, 10 min, 30 min 60 min during surgery 
and at extubation. 
The clonidine group had statistically significant  low pulse rate, systolic 
and diastolic blood pressure on induction and 5, 10 mins post gas insufflation. 
The haemodynamics at 30 mins, 60 mins and at extubation were almost 
comparable and no significant difference was noted. There was a significant fall 
in pulse rate and systolic blood pressure in clonidine group at  5, 10 mins post 
insufflation as compared to baseline  which was not seen in the control group. 
Forty patients of the non- clonidine group required esmolol or propofol as 
infusion, intraoperatively to maintain the pressures within the constraints of the 
aim of the study. They  administered glycopyrrolate 0.2 mg for 3 patients when 
there was bradycardia of 50/min or below in the clonidine group. They 
concluded that oral clonidine premedication is advantageous because of 
• Decreased pressor response to laparoscopy and pneumoperitoneum  
• Maintenance of haemodynamic parameters  
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• No side effects other than bradycardia  which was easily treatable.  
A. Islam et al(2008)  studied  the role of oral clonidine and atenolol in 
controlling tachycardia and hypertension associated with pneumoperitoneum  
with CO2 during laparoscopic cholecystectomy. Patients were divided equally 
into three groups, which were Group-I: Oral clonidine(150ìgm), Group-II: oral 
atenolol(25mg) and Group-III: placebo (vitamin-c tablet), twenty five patients 
were in each group. The premedication was given 60 to90 min prior to 
induction. They compared hemodynamic variables at various points- before 
induction, after intubation, after skin incision, after insufflation, 5 min, 10 min, 
15 min, 20 min after insufflations. The mean pulse rate was significantly low in 
Clonidine premedicated patients at all points except just before induction and 
just after insufflations. The decline in pulse rate from induction through the 
surgery was also notably low in the Clonidine group. They didn’t observe 
significant difference in the systolic, diastolic and mean arterial pressures, 
though there was a lowering of blood pressure in clonidine group. They noted 
that anaesthetic and analgesic requirement was less in Clonidine group and the 
recovery scores were almost similar in all three groups. 
Sung et al(2000) from Taipei randomly allotted one hundred and ten 
patients, scheduled for elective laparoscopic cholecystectomy to either of the 
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placebo or clonidine group. Those in the clonidine group (n = 45) were 
premedicated with oral clonidine 150 micrograms 60- 90 mins prior to 
anesthesia. Normocapnia was maintained through out the procedure. Patients in 
the clonidine group displayed greater hemodynamic stability perioperatively 
and the isoflurane requirement was also reduced (30% less). The post operative 
analgesic requirement was also less in Clonidine treated patients. 
Norimasa et al (2009) from Jichi medical university, Japan, used oral 
clonidine premedication and compared it against  Atropine-hydroxyzine, for 
premedication in laproscopic cholecystectomy, 20 patients in each group .They 
concluded that oral clonidine has an anaesthetic sparing and hemodynamic 
stabilizing effect during laproscopic cholecystectomy.Heart rate in the clonidine 
group was significantly lower at various points during the surgery  compared to 
the other group. They didn’t observe a significant difference in the mean arterial 
pressures. 
Yu et al, (2003) had done a study to investigate the clinical efficiency of 
oral clonidine premedication in anaesthesia and analgesia  in 32 patients 
undergoing laproscopic cholecstectomy.  Of them, 16  patients received oral 
clonidine 150 μg and rest 16 placebo control received oral antacid 
(alugelhydroxide 300 mg) before anaesthesia.  They used heart rate variability 
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to quantify heart rate control at baseline, pneumoperitoneum and recovery 
periods. They found that  oral clonidine preserved the heart rate control during 
pneumoperitoneum and recovery. 
 Yotsui et al(2001) from Japan, investigated the effects of oral 
administration of clonidine on sympathetic and endocrinological responses to 
laproscopic cholecystectomy. They did the study in twenty patients, 10 in the 
clonidine group- 4µg/kg and 10 in the control group- placebo, given 2 hours 
prior to surgery. The hemodynamic variables were observed perioperatively. 
Plasma concentrations of cortisol, ACTH, noradrenaline, adrenaline, and 
dopamine were determined before administration of clonidine or placebo, 2 h 
after the beginning of the operation, and 3 h after the end of the operation.  
Systolic and diastolic blood pressures were lower in the clonidine group than in 
the control group immediately after endotracheal intubation and extubation . 
Patients in the clonidine group showed lower plasma concentrations of 
noradrenaline 2 h after the beginning of the operation than patients in the 
control group. The plasma concentrations of the other hormones did not differ 
between groups. 
Joris et al(1998) from American College of Cardiology investigated 
endocrine correlates of the hemodynamic changes induced by carbon dioxide 
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pneumoperitoneum (PNO) and also studied whether clonidine might modulate 
the hemodynamic changes induced by PNO by reducing release of 
catecholamines and vasopressin. Laparoscopy resulted in progressive and 
significant increases in plasma concentrations of cortisol, epinephrine, 
norepinephrine, vasopressin and renin. Clonidine significantly reduced mean 
arterial pressure, heart rate and the increase in systemic vascular resistance. 
Clonidine also significantly reduced catecholamine concentrations but did not 
alter vasopressin and cortisol plasma concentrations. 
Javaherfroosh et al(2009) studied the efficacy of oral clonidine (0.2mg) in 
controlling post operative nausea and vomiting (PONV) in patients undergoing 
laproscopic gyaenecologic surgeries. Clonidine significantly reduced PONV 
and no case of significant hypoxemia, drop in blood pressure or heart rate was 
noted. Post operative pain scores were also less. They have recommended 
routine use of clonidine before Laproscopy. 
Oh SW et al (2002) used intravenous Clonidine 150µg  as premedication 
for Laproscopically assisted vaginal Hysterectomy. When compared with 
control group (saline), they observed a significantly lower pulse rate and blood 
pressure after insufflation  in the clonidine group. 
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M.Uchida et al (2004) examined the hemodynamic responses to 
hypercapnia during propofol and isoflourane anaesthesia and compared them in 
presence and absence of Clonidine premedication- 5µg/ kg, 90 min prior to 
surgery. They measured mean arterial pressure, cardiac index, and heart rate at 
ETCO2 values of 35 and 55mmHg by adding CO2 to the inspired gas. All 
variables were significantly lower in the Propofol- Clonidine sub group than the 
other three sub groups. They attributed the results to a profound suppression of 
sympathoadrenal activity due to interaction between the basal anaesthetic and 
premedicant.  
Talebi et al(2010) studied Effects of Oral Clonidine Premedication on 
Haemodynamic Response to Laryngoscopy and Tracheal Intubation. 274 ASA I 
and II subjects were randomly allocated to receive oral clonidine (0.2 mg) or 
placebo as premedication 90-120 min before induction. Both heart rate and 
systolic blood pressures were significantly higher in Control group at three 
subsequent measurements following intubation. 
D L Raval et al(2002) used oral Clonidine - 4µg/ kg, 90 min prior to 
induction and found that it significantly blunted the pressor response to 
laryngoscopy and intubation. 
 
27 
 
 
STATISTICAL ANALYSIS 
 All data were collected, tabulated and expressed as Mean ± Standard 
Deviation. Statistical analysis was done with MINITAB software. All data were 
normal and stable. Hence,  comparative analysis of the means of two groups 
was done by Two sample- T Test. The variances were compared by F- Test.  P 
value of less than 0.05 was considered statistically significant.  
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OBSERVATION AND RESULTS 
 The demographic profile in both groups was comparable and no 
significant difference was observed. 
AGE 
Group Mean(yrs) Standard deviation Statistical significance
Group –P 31.4 12.1 
P =0.943 
Group – C 31.6 11.6 
 
SEX 
Group Male Female 
Group P 11 14 
Group C 12 13 
 
All the patients belonged to ASA I physical status in both groups. 
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WEIGHT 
Group Mean(kg) Standard deviation Statistical significance
Group -P 56.2 7.37 
P =0.586 
Group - C 57.32 7.06 
 
 
 
 
SURGICAL PROCEDURE 
Group Appendicectomy Cholecystectomy 
Group P 18 7 
Group C 17 8 
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The baseline hemodynamic variables before ingestion of premedication 
drug (Clonidine or placebo) were also comparable between the groups.  
BASELINE HEART RATE 
Group Mean(bpm) Standard deviation Statistical significance
Group -P 82.5 14.3 
P =0.967 
Group - C 82.4 13.0 
 
   
BASELINE SYSTOLIC BLOOD PRESSURE 
Group Mean(mmHg) Standard deviation Statistical 
significance 
Group -P 119.3 10.6 
P =0.861 
Group - C 119.8 10.3 
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BASELINE DIASTOLIC BLOOD PRESSURE 
Group Mean(mmHg) Standard deviation Statistical 
significance 
Group –P 79.44 7.52 
P = 0.555 
Group – C 78.12 8.1 
 
  
 
BASELINE MEAN ARTERIAL PRESSURE 
Group Mean(mmHg) Standard deviation Statistical 
significance 
Group -P 92.52 7.41 
P =0.913 
Group - C 92.28 8.06 
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HEART RATE 
The mean heart rate was significantly low in Group C when compared 
with Group P at all points of time. (P < 0.05) 
Time Group Mean Standard deviation Statistical Significance 
On table 
After study drug 
P 86.8 16.3 P - 0.003 (HS) 
F test - P - 0.672 
 C 73 14.9 
Just after Intubation 
  
P 100.9 13.9 P - 0.00* (HS) 
F test - P - 0.121 
 C 76.7 10 
5 Min after Intubation 
  
P 83.2 15.1 P - 0.00* (HS) 
F test - P - 0.203 
 C 64 11.6 
5 Min after Pneumo 
peritoneum 
  
P 79 15 P - 0.00* (HS) 
F test - P - 0.004 
 C 63.08 8.11 
15 Min after Pneumo 
peritoneum 
  
P 79.8 16.3 P - 0.00* (HS) 
F test - P - 0.001 
 C 63.28 7.92 
30 Min after Pneumo 
peritoneum 
  
P 78.5 15.4 P - 0.00* (HS) 
F test - P - 0.001 
 C 63.8 7.57 
After extubation 
  
P 95.4 15.8 P - 0.00 * (HS) 
F test - P - 0.383 
 C  74.3  13.2 
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SYSTOLIC BLOOD PRESSURE 
 The difference in mean systolic blood pressure was statistically 
significant (P<0.05) at all points from pre- induction to after extubation and 
Group P patients had higher values. 
Time Group Mean Standard deviation Statistical Significance 
On table 
After study drug 
P 123.2 10.6 P - 0.00* (HS) 
F test - P - 0.131 
 C 113.9 14.5 
Just after Intubation 
  
P 141.6 19.8 P - 0.00* (HS) 
F test - P - 0.661 
 C 115.4 18.1 
5 Min after Intubation 
  
P 117.4 20.9 P - 0.003  (HS) 
F test - P - 0.013 
 C 102.2 12.4 
5 Min after Pneumo 
peritoneum 
  
P  139.16  11.4  P -0.00* (HS) 
F test – P -0.851 C  121.84  10.2 
15 Min after Pneumo 
peritoneum 
  
P 139.6 10.8 P - 0.00* (HS) 
F test - P - 0.04 
 C 121.1 16.5 
30 Min after Pneumo 
peritoneum 
  
P 136.4 13.9 P - 0.001  (HS) 
F test - P - 0.612 
 C 121 15.5 
After extubation 
  
P 139.6 13.7 P - 0.00* (HS) 
F test - P - 0.352 C 121 11.3 
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DIASTOLIC BLOOD PRESSURE 
 Clonidine premedicated patients (Group C) were found to have 
significantly low diastolic blood pressure values (P <0.05) when compared to 
the placebo group (Group P) at all points of time. 
Time Group Mean Standard deviation Statistical Significance 
On table 
After study drug 
P 84.04 8.16 P - 0.00* (HS) 
F test - P - 0.425 C 71.84 9.62 
Just after Intubation 
 
P 96.6 18.4 P - 0.00* (HS) 
F test - P - 0.304 C 73.6 14.9 
5 Min after Intubation 
 
P 79.2 14.8 P - 0.001  (HS) 
F test - P - 0.107 C 65.7 10.6 
5 Min after Pneumo 
peritoneum 
 
P 98.88 9.8 P - 0.00* (HS) 
F test - P - 0.003 
 C 77.5 18.4 
15 Min after Pneumo 
peritoneum 
 
P 96.8 8.63 P - 0.00 * (HS) 
F test - P - 0.546 C 80.1 10.7 
30 Min after Pneumo 
peritoneum 
 
P 94.12 9.33 P - 0.00 * (HS) 
F test - P - 0.712 
 C 80.8 10.1 
After extubation 
 
P 92.72 8.47 P - 0.00 * (HS) 
F test - P - 0.654 
 C 79.44 7.72 
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MEAN ARTERIAL PRESSURE 
 Since systolic and diastolic blood pressures were lower, the mean 
arterial pressure was also significantly lower in Group C than in Group P (P 
<0.05) at all instances.  
Time Group Mean Standard deviation 
Statistical 
Significance 
On table 
After study drug 
P 98.24 8.03 P - 0.00 * (HS) 
F test - P - 0.170 C 86.4 10.7 
Just after Intubation 
  
P 111.2 17.4 P - 0.00 * (HS) 
F test - P - 0.557 C 87.7 15.4 
5 Min after Intubation 
  
P 91.8 15.7 P - 0.001 (HS) 
F test - P - 0.069 C 77.8 10.7 
5 Min after Pneumo 
peritoneum 
  
P 111.9 9.6 P - 0.00 * (HS) 
F test - P - 0.065 
 C 94.9 14.1 
15 Min after Pneumo 
peritoneum 
  
P 110.56 7.91 P - 0.00 * (HS) 
F test - P - 0.033 C 94 12.4 
30 Min after Pneumo 
peritoneum 
  
P 107.76 9.73 P - 0.00 * (HS) 
F test - P - 0.451 C 93.4 11.4 
After extubation 
  
P 108.28 9.73 P - 0.00 * (HS) 
F test - P - 0.458 
 C 93.12 8.34 
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   Review of literature indicates that hemodynamic perturbations 
during laproscopy occur most commonly at the start of pneumoperitoneum(20). 
With this in mind, the percentage change in hemodynamic variables between 
baseline values and the values noted at 5 min after insufflation was calculated 
and the mean values plotted. 
 After 5 min of pneumoperitoneum, heart rate was found to be 
lower than baseline in both groups but, the %  decrease  was steeper in Group C. 
 Systolic blood pressure and mean arterial pressure increased on 
insufflations, but the % increase from baseline was very meagre in Group C. 
After insufflations, diastolic blood pressure was found to be higher than 
baseline  in Group P whereas it was much lower than baseline in Group C 
Group Heart rate Systolic blood 
pressure 
Diastolic blood 
pressure 
Mean arterial 
pressure 
Group P -7.27% +13.95% +19.03% +16.97% 
Group C -31.4% +0.02% -24.8% +1.12% 
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ADVERSE EVENTS 
 The incidence of adverse events in the form of extremes of the 
hemodynamic variables in both groups was noted. 
 Three patients in Group P developed hypertension which required 
treatment with Nitroglycerine infusion. None of the patients in Group C 
developed hypertension. 
 Three  patients in Group C developed bradycardia and were treated 
with bolus dose of Inj.Atropine 0.6 mg i.v. One patient developed hypotension, 
and was given single bolus of Ephedrine 6 mg i.v. None of the patients in Group 
P developed bradycardia or hypotension. 
INCIDENCE OF ADVERSE EVENTS 
Event Group P 
(No of patients)
Group C 
(No of patients)
Hypertension 3 0 
Bradycardia 0 3 
Hypotension 0 1 
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DISCUSSION 
Pneumoperitoneum during laparoscopy produces significant 
haemodynamic changes, which can be detrimental especially in elderly and 
haemodynamically compromised patients. Various techniques and 
pharmacological agents have been used to counteract these detrimental effects 
of pneumoperitoneum. This  prospective study was carried out in 60 adult 
patients, to evaluate the effect of clonidine premedication in attenuating 
haemodynamic stress response associated with pneumoperitoneum. 
The preferred anaesthetic technique for laproscopic surgery is general  
anaesthesia with muscle paralysis, tracheal intubation and intermittent positive 
pressure ventilation(20, 21). Although regional anaesthesia is possible, need for 
high level of blockade, high incidence of post operative shoulder pain, increased 
patient discomfort and anxiety, high minute ventilation needed to maintain 
normocarbia during spontaneous ventilation are disadvantages. All the patients 
in our study were given general anaesthesia with controlled ventilation. 
Clonidine is completely absorbed after oral administration and clinical 
effect. The sympatholytic action starts manifesting by 30 to 60 min. Almost all 
the reference studies had given clonidine 60 to 90 min prior to surgery and in 
our study too clonidine was given at around the same time. 
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Adequate preoperative volume loading is an intervention with Grade A 
scientific evidence in preventing cardiovascular complications of 
laproscopy(22). All patients were preloaded with 10 ml/ kg Ringer Lactate. 
Propofol was chosen for induction and maintenance of anaesthesia, 
because it was found to provide stable hemodynamics, fast recovery, and less 
post operative side effects  during laproscopy(17,23,24). Vecuronium was the 
muscle relaxant of choice in this study, because of its cardiostable profile. 
In ASA I-II patients, the haemodynamic and circulatory effects of a 
12 - 14 mmHg capnoperitoneum are generally well tolerated(22). Following 
induction of pneumoperitoneum, the intra abdominal pressure was maintained 
below 14 mmHg and in the range of 12-14 mmHg. 
 Since hypercapnia is a major contributor to hemodynamic perturbations 
during pneumoperitoneum, patients were hyperventilated to maintain 
normocapnia (i.e) ETCO2 was maintained in the range of 35- 40 mmHg.  
 Demographic profile including age, sex, surgical procedure, weight were 
comparable between both groups. With regards to sex distribution in our study, 
males and females were almost equal in number. This is in contrast to other 
studies where females were more in number. The studies referred were done in 
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patients undergoing either cholecystectomy or gyaenecological surgeries, 
whereas our study included patients who underwent both cholecystectomy and 
appendicectomy, which can explain this difference.  
 The baseline hemodynamic variables (before ingestion of study drug- 
BSD)  were comparable between the groups. 60-90 min after the study 
drug(ASD),  heart rate(HR), systolic, diastolic and mean arterial pressures 
(SBP, DBP & MAP) were lower than the baseline in Group C,  whereas it was 
higher in Group P. 
 HR(bpm) SBP (mmHg) DBP(mmHg) MAP(mmHg) 
BSD ASD BSD ASD BSD ASD BSD ASD 
Group   
P(avg) 
82.5 86.8 119.3 128.8 79.4 84.1 92.5 98.3 
Group 
C(avg) 
82.3 73.1 119.8 113.9 78.1 71.8 92.2 86.4 
 
 Intake of  Clonidine had produced a considerable decrease in the 
variables after 60 to 90 min. Literature shows that the pharmacological effects 
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start appearing by 60 min(5, 10)  which  is well correlated here, and 
sympatholysis is manifested. The sedative- anxiolytic property of clonidine 
could also have contributed to this decrease noted preoperatively. Y. Passi et al, 
M. Das et al, A. Islam et al and M.Sinha et al had similar observations after 
clonidine premedication. 
 Just after intubation and 5 min fter intubation, the heart rate, systolic 
diastolic and mean arterial pressures were significantly lower in Group C 
compared to Group P. This is comparable to the results of the studies on effect 
of oral clonidine in blunting response to laryngoscopy and intubation done by 
Talbei et al and Raval & Mehta(18, 19). 
EFFECT ON HEART RATE 
The mean heart rate was significantly  low  in Group C at all points of 
time during the surgery. On insufflation, the mean heart rate was foud to be less 
than baseline in both groups, may be contributed to propofol anaesthesia. But, 
the decrease in Group C was 31.4%  against a 7.27% decrease in Group P, 
clearly indicating the role of Clonidine premedication. Compared to baseline , 
significant decline in mean pulse rate was seen after 5 and 10 min of 
insufflation in the study by M.sinha and S.Goel(10). 
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 Heart rate varied from 78.5 ±15.4  to 100. 9 ± 13.9(bpm) in Group P and 
from 63.08 ± 8.1 to 82.4 ± 13(bpm) in Group C. Y.passi et al(8) and M. Das et 
al(9) have obtained similar results in their placebo controlled studies and mean 
pulse rate was significantly low in clonidine premedicated patients at all 
instances noted. A. Islam et al(11)  observed significant decrease in pulse rate in 
Clonidine group than both Atenelol and placebo. Norimasa S et al(1) also 
observed significantly low heart rate in patients premedicated with Clonidine 
than in those with Atropine Hydroxyzine  at all times throughout the surgery. 
 
EFFECT ON SYTOLIC BLOOD PRESSURE 
From pre-induction to post extubation, mean systolic blood pressure was 
significantly lower in Group C than Group P. On induction of 
pneumoperitoneum, the mean systolic pressure values were found to be higher 
than baseline values  in both groups. But, the increase was 13.95% in Group P 
and just 0.02% in Group C.  The mean systolic blood pressure varied from 117± 
20.9 to 139.6 ± 13.7(mmHg) in group P and from 102.24 ± 12.4 to 121.0 ± 
15.5(mmHg) in Group C. 
M. Das et al(9), Y. Passi et al(8) and Youtsi et al(14)  in their studies 
noted a significant lowering of systolic blood pressure in patients premedicated 
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with Clonidine, compared to the placebo Group. Patients in the Clonidine group 
had significantly low systolic pressure at 5, 10 minutes after insufflations, as 
observed by M. Sinha and S.Goel(10). These observations correlate well with 
our study. 
 
EFFECT ON DIASTOLIC BLOOD PRESSURE 
Diastolic pressure also consistently remained low all through  the surgery 
in Group C. The mean diastolic pressure varied from  79.16 ± 14.8 to 98.9±  
10.8(mmHg)     in Group P and from 65.72 ±  10.6 to 80.76 ± 10.1(mmHg)     in 
Group C. On insufflation, the change in diastolic pressure from baseline was a 
profound decrease of   up to 24.8% in Group C, while it was  19.3%  higher 
than baseline in Group P. 
A.Islam et al(11)  compared  Clonidine, Atenelol and Placebo for 
premedication in Laproscopic cholecystectomy. They observed that decline in 
diastolic blood pressure from baseline was more in Clonidine group and  the 
mean diastolic blood pressure remained lower than the other groups, though not 
statistically significant.  M .Das et al(9) , M. Sinha & S. Goel(10), Youtsi et 
al(14)  have obtained results consistent  with our observations. 
44 
 
EFFECT ON MEAN ARTERIAL PRESSURE 
Joris et el(1)  studied the hemodynamic changes during laproscopy and 
measured the mean arterial pressure, heart rate, cardiac output and systemic 
vascular resistance. 39± 8 % increase in MAP was noticed on peritoneal 
insufflations and they  also noted a significant blunting of this response on 
administration of Clonidine. In our study the average mean arterial pressure 
varied from 95.52 ± 7.41 to 111.9 ±9.6 in Group P and from 77.8 ±10.7  to 94.9 
±14.1  in Group C. The mean arterial pressure on insufflation  was 16.9%  
higher than baseline in Group P , while it was only 1.12% higher in Group C. 
This observation is supportive of  the evidence that clonidine blunts the increase 
in MAP. 
On induction of pneumoperitoneum more than 20% increase in mean 
arterial pressure was noted by M. Das et al(9)  in  placebo group, while it never 
crossed the baseline value in  Clonidine group.  A. Islam et al(11) observed a 
steeper decline in MAP in patients premedicated with Clonidine than in those 
premedicated with  Atenelol or Placebo. Y. Passi et al(8) observed  that  mean 
arterial pressure was consistently lower in the clonidine group than placebo 
group at all points through the surgery. All these results are consistent with 
results of this study. 
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In trying to explain the hemodynamic changes during laproscopy and 
pneumoperitoneum, Joris et al(1)  also studied the endocrine correlates of these 
hemodynamic changes. They found that laproscopy resulted in progressive and 
significant increase in plasma concentrations of cortisol, epinephrine, 
norepinephrine, rennin and vasopressin.  Administration of  8µg/ kg clonidine 
as an intravenous  infusion prior to surgery, significantly reduced catecholamine 
concentrations, but did not alter vasopressin or cortisol concentration. 
Youtsi et al(14)  studied the endocrine responses and concluded that  
Clonidine premedication prevents sympathetic hyperactivity but does not 
suppress hypothalamic- pitutary adrenal  response to laproscopy. As we have 
already discussed the cardiovascular changes during laproscopy is primarily 
mediated by neuro humoral responses(4). The blunting of these perturbations by 
Clonidine consist of at least three different components(26) 
A.  Central activation of  α -2 adrenoceptors: 
1. Reduction in peripheral sympathetic tone. 
2. Increase in vagally induced bradycardia. 
B. Peripheral stimulation of presynaptic  α- 2 adrenoceptors: 
3. Diminished release of norepinephrine from nerve endings.  
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 Sung et al(12)  used 150µg oral clonidine as premedicant for laproscopic 
cholecystectomy and concluded that it provides a stable hemodynamics. Our 
study results  supports this conclusion. 
 Three  patients (12%) in Group P developed hypertension. In studies by 
M.Das(9)  et al and  Y. Passi et al(8) 33%, 36% patients in placebo group 
required  nitroglycerine for treatment of hypertension.  The lower incidence in 
our study can be due to Propofol anaesthesia whereas Isoflourane was used for 
maintenance of  anaesthesia in the above studies. Also  MAP > 110 mmHg was 
treated by Y.passi, while we treated MAP > 120 mmHg. 
 Bradycardia  was noticed in three patients(12%)  in Group C and none in 
Group P. The incidence  was 4% and 6% respectively in studies by Y. Passi et 
al(8) and M. Sinha & S. Goel(10)  respectively.  Bradycardia was transient and 
was easily treatable with single bolus dose of  0.6 mg of  Inj. Atropine after 
which repeat boluses were not required. 
 Hypotension was noted in one patient (4%)  in Group C. Y. Passi et al(8) 
observed a similar incidence (i.e) one out of  25 patients in clonidine group 
developed hypotension. None of the patients had hypotension in studies by M. 
Das et al and M. Sinha & S. Goel(10). The treatment required a single bolus of 
inj. Ephedrine 6 mg i.v  and not more than that.  
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 Other uses of clonidine in laproscopic surgeries as observed by 
Javaherfroosh et al(15), Talbei et al(18), Raval & Mehta(19), M Das et al(9), Y 
Passi et al(8), Oh SW  et al(16), Youtsi et al(14),  M. Sinha and S. Goel(10)  are 
• Sedating property 
• Anaesthetic and analgesic sparing effect 
• Anxolytic effect 
• Reduced incidence of nausea and vomiting 
• Reduced postoperative shivering   
• Reduced blood sugar levels intraoperatively 
• Drying of  secretions. 
• Blunting of hemodynamic response to intubation 
• Minimal incidence of side effects which are easily treatable 
 Oral Clonidine is an age-old and cheap drug. Considering all these 
observations along with ours, oral Clonidine Premedication is definitely a cost 
effective method in attenuating the untoward hemodynamic changes during 
Pneumoperitoneum. 
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SUMMARY 
 This prospective randomised case control study was done to evaluate the 
efficacy of oral clonidine premedication in blunting the hemodynmic response 
to laproscopy and pneumoperitoneum. 50 patients of either sex, aged 16- 65 
years, belonging to ASA physical status I or II undergoing either laproscopic 
cholecystectomy or appendicectomy were chosen for the study. They were 
randomised to two groups  C and P, 25 patients each, to receive either Clonidine 
150 µg or placebo orally as premedicant 60-90 min prior to surgey. 
 The hemodynamic variables heart rate, systolic, diastolic and mean 
arterial pressures were compared  between the groups at seven points  during 
the surgery. 
• On table- before induction. 
• Just after intubation 
• 5 min after intubation 
• 5 min after insufflation 
• 15 min after insufflation 
• 30 min after insufflation 
• After  extubation 
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      The incidence of adverse events in the form of bradycardia, hypotension, 
and hypertension was noted in both groups. The results obtained were: 
1. Significantly higher values of hemodynamic variables in Group P than 
Group C, at all the instances. 
o Mean heart  rate varied from 78.5 ±15.4  to 100. 9 ± 13.9 in Group 
P and from 63.08 ± 8.1 to 82.4 ± 13 in Group C.(P <0.05 ) 
o The mean systolic blood pressure varied from 117± 20.9 to 139.6 ±             
13.7 in group P and from 102.24 ± 12.4 to 121.0 ± 15.5 in Group 
C.(P <0.05) 
o The mean diastolic pressure varied from  79.16 ± 14.8   to 98.9±  in 
Group C.(P <0.05) 
o  The average mean arterial pressure varied from 95.52 ± 7.41  to 
111.9 ± 10.6 in Group P and from 77.8 ± 10.7  to 94.9 ± 14.1 in 
Group C. (P< 0.05) 
2. Hypertension was not seen in Group C, while 3 patients in Group P 
developed hypertension. However 3 patients in Group C developed 
bradycardia and one had intraoperative hypotension, both of  which 
were easily treatable with drugs. 
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CONCLUSION 
   Premedication with oral clonidine 150µg , 60-90 min prior to laproscopic 
surgeries in adults can effectively blunt the hemodynamic response to 
pneumoperitoneum . Routine use can be recommended because of this 
advantage and minimal, easily treatable side effect profile. Further studies are  
needed to evaluate the usefulness of this drug as premedication for laproscopic 
surgeries in   patients with limited cardiac reserve. 
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PROFORMA 
• Consent obtained? : 
• Name of the patient:  
• Age: 
• Sex: 
• Weight: 
• Proposed Surgery: 
• ASA Physical status: 
• Comorbid illness: 
• Time of giving clonidine / placebo: 
• Time of Induction: 
• Duration of surgery: 
S.no Parameters HR Systolic BP Diastolic BP MAP 
1 Before clonidine  
administration 
    
2 On table- baseline     
3 Just after intubation     
4 At 5 minutes after 
intubation 
    
5 At 5 minutes after 
insufflation 
    
6 At 15 minutes after 
insufflation 
    
7 At 30 minutes after 
insufflation 
    
8 After extubation     
 
• Any adverse events / treatment                   : 
     (Bradycardia / Hypotension / Hypoxemia) 
57 
 
MASTER CHART 
S.NO Group Age Sex Weight Surgery ASA-PS Duration HR-BSD HR-ASD HR-JA I HR-5min I HR-5min PP HR-15min PP HR-30min PP HR-AE SBP-BSD SBP-ASD SBP-JAI SBP-5min I SBP-5min PP SBP-15min PP SBP-30min PP SBP- AE
1 P 55 M 67 Chole 1 78 100 102 112 108 118 101 102 102 130 130 172 170 148 144 147 138
2 P 19 F 50 App 1 46 80 88 112 84 99 96 96 109 120 122 153 99 147 144 141 136
3 P 28 M 56 APP 1 50 84 100 94 76 58 64 64 92 123 135 143 116 138 141 126 144
4 P 48 F 50 App 1 45 84 96 101 74 60 60 77 104 130 136 134 123 139 139 145 145
5 P 34 M 58 App 1 60 90 92 113 65 61 56 55 76 110 127 170 109 138 123 100 140
6 P 34 M 62 App 1 49 64 60 119 91 91 92 74 88 124 133 161 157 157 153 135 136
7 P 16 F 42 App 1 47 90 95 103 95 79 85 85 94 110 123 105 92 122 118 109 126
8 P 30 F 75 Chole 1 90 94 107 100 90 93 96 96 94 140 153 152 106 148 138 146 148
9 P 41 M 60 Chole 1 106 84 86 91 75 78 64 70 82 134 146 172 134 156 151 152 144
10 P 23 M 54 App 1 52 58 61 74 59 57 54 52 64 110 127 138 107 143 147 152 157
11 P 27 M 49 App 1 55 88 85 110 103 80 74 76 90 124 130 136 110 141 148 150 139
12 P 60 M 64 Chole 1 98 72 70 86 103 95 104 99 92 108 121 148 103 126 141 146 137
13 P 26 M 55 App 1 55 74 71 95 87 80 90 79 88 110 128 135 154 152 155 157 156
14 P 37 F 52 Chole 1 72 108 116 123 114 69 83 81 123 120 133 173 140 133 146 136 148
15 P 28 F 48 App 1 70 112 110 114 76 79 72 79 121 110 110 140 108 131 134 121 160
16 P 42 F 52 App 1 64 70 76 84 62 82 87 88 115 100 106 115 95 124 136 141 134
17 P 30 F 50 App 1 53 80 84 110 86 59 69 59 109 120 125 130 125 133 134 133 150
18 P 20 F 58 App 1 52 82 97 99 71 86 95 80 103 126 137 122 99 149 144 131 125
19 P 18 F 54 App 1 49 85 89 110 98 87 87 96 94 116 122 116 100 114 121 135 142
20 P 20 M 62 App 1 54 72 75 93 75 62 60 70 93 128 130 120 116 131 130 135 150
21 P 24 F 65 Chole 1 110 108 110 126 99 92 114 106 114 140 145 157 134 149 155 154 160
22 P 18 F 50 App 1 48 80 94 95 75 87 76 79 112 110 119 119 99 126 124 124 129
23 P 26 F 50 App 1 60 60 60 77 68 68 65 50 77 110 116 146 108 140 133 122 126
24 P 51 M 62 Chole 1 82 74 72 95 72 76 75 72 64 110 128 158 131 158 154 137 101
25 P 30 F 60 App 1 38 70 75 86 73 80 75 77 97 120 124 126 100 136 136 134 119
1 C 19 F 48 App 1 80 65 58 67 58 64 55 60 79 110 115 96 106 122 124 126 124
2 C 55 F 55 Chole 1 99 74 68 68 52 61 63 61 76 120 118 138 124 153 148 152 132
3 C 32 F 64 App 1 45 60 50 55 38 56 52 56 57 120 125 115 108 108 119 124 124
4 C 25 M 60 App 1 64 90 75 81 71 62 65 65 75 130 118 115 110 113 112 114 113
5 C 36 F 62 Chole 1 95 78 70 76 69 60 61 57 90 120 110 109 103 93 92 92 132
6 C 21 M 58 App 1 57 80 67 74 61 64 70 66 89 120 93 106 96 120 119 118 130
7 C 30 F 55 App 1 54 108 86 77 77 79 72 74 86 100 96 88 83 96 101 105 101
8 C 39 M 54 Chole 1 79 76 71 83 74 63 60 60 81 110 102 103 102 124 123 117 124
9 C 48 F 65 Chole 1 106 80 76 81 73 66 69 60 84 130 140 134 106 134 149 147 131
10 C 33 F 60 App 1 48 88 74 85 67 59 69 66 74 130 122 114 109 118 140 135 123
11 C 26 M 54 App 1 46 76 74 77 52 60 56 57 43 120 119 125 108 134 136 137 107
12 C 28 F 70 Chole 1 84 90 100 76 76 71 78 81 71 130 130 148 113 152 149 144 124
13 C 18 M 45 App 1 54 74 65 74 52 51 65 61 71 100 99 89 85 110 101 107 110
14 C 23 M 52 App 1 59 60 49 58 42 51 50 54 47 110 107 90 90 90 109 114 116
15 C 33 F 49 App 1 47 78 55 74 67 54 54 55 75 110 99 138 84 116 108 108 115
16 C 23 F 55 App 1 54 106 91 94 64 68 68 67 78 130 118 125 115 137 126 117 117
17 C 33 M 65 App 1 65 86 93 88 81 66 68 66 83 120 117 115 93 124 116 120 116
18 C 42 M 59 App 1 72 86 79 74 54 51 51 61 56 140 111 143 117 116 116 112 102
19 C 24 M 64 App 1 66 104 59 90 71 75 67 76 84 114 116 124 117 126 121 134 127
20 C 23 M 60 App 1 39 74 67 71 60 69 66 69 77 118 93 93 76 108 107 103 120
21 C 37 F 62 Chole 1 94 80 67 61 50 50 53 50 54 130 134 121 93 148 141 125 150
22 C 18 M 45 App 1 49 86 87 88 77 64 65 68 82 120 110 112 101 119 106 102 117
23 C 25 F 45 App 1 58 90 75 90 75 71 68 71 90 120 103 114 115 123 115 128 118
24 C 35 F 65 Chole 1 120 70 62 72 69 77 77 74 85 110 102 92 95 152 143 138 111
25 C 65 M 62 App 1 44 100 108 83 69 65 61 60 70 134 150 139 107 110 107 107 140  
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S.NO Group DBP-BSD DBP-ASD DBP-JAI DBP-5min I DBP-5min PP DBP-15 minPP DBP-30min PP DBP-AE MAP-BSD MAP-ASD MAP-JAI MAP-5min I MAP-5min PP MAP-15min PP MAP-30min PP MAP- AE Adv Events
1 P 90 88 111 110 95 94 96 86 103 103 131 130 113 111 115 103 Ntg-5µ/Kg/min
2 P 80 76 90 68 110 107 104 95 93 91 111 78 122 120 116 108 nil
3 P 90 90 95 76 104 102 86 95 101 105 111 89 115 115 99 112 nil
4 P 90 87 95 81 95 96 106 105 97 103 108 95 110 110 119 118 nil
5 P 80 92 120 74 92 93 72 90 90 104 137 86 107 103 81 107 nil
6 P 86 90 109 104 114 111 94 92 99 104 126 122 128 125 108 107 Ntg-5µ/Kg/min
7 P 76 82 72 65 95 90 81 91 89 95 83 74 104 99 90 103 nil
8 P 90 100 102 76 101 96 99 99 107 119 119 86 117 110 115 115 nil
9 P 86 90 108 86 113 104 103 90 102 108 129 102 127 119 119 108 nil
10 P 70 77 82 71 80 81 79 104 83 90 100 83 101 103 103 123 nil
11 P 70 80 88 74 102 107 107 94 85 96 103 86 115 120 120 110 nil
12 P 76 74 108 73 92 102 101 88 87 90 121 83 103 115 116 104 nil
13 P 80 75 80 85 92 87 92 92 90 95 98 108 112 110 114 113 nil
14 P 70 104 145 118 106 113 110 99 87 104 145 118 106 113 110 115 nil
15 P 80 76 112 75 92 96 86 100 90 87 122 86 105 109 98 117 nil
16 P 68 75 73 63 94 94 96 89 82 85 87 74 104 108 111 104 nil
17 P 80 84 105 87 100 100 96 98 93 98 113 100 111 111 108 115 nil
18 P 80 86 81 64 104 95 93 82 95 103 95 76 119 111 106 96 nil
19 P 84 85 74 68 81 84 91 104 95 97 88 82 92 96 106 117 nil
20 P 70 75 67 67 95 92 91 90 89 93 85 83 107 104 106 110 nil
21 P 90 90 107 95 99 96 99 110 107 108 124 108 116 116 117 127 nil
22 P 70 79 79 66 89 84 85 88 83 92 92 77 101 97 96 102 nil
23 P 70 73 107 71 112 90 88 81 83 87 120 83 121 104 99 96 nil
24 P 80 85 115 92 119 110 103 74 90 99 129 105 133 125 114 83 Ntg-5µ/Kg/min
25 P 80 88 90 70 96 96 95 82 93 100 102 80 109 109 108 94 nil
1 C 60 58 54 76 74 79 83 86 77 80 68 86 90 94 97 99 nil
2 C 78 67 90 70 91 89 90 91 92 84 106 88 112 109 111 104 nil
3 C 70 65 60 58 73 67 71 74 87 85 78 75 85 84 88 91  A-0.6mg (once)
4 C 90 77 77 72 75 75 72 82 103 91 90 85 87 87 84 92 nil
5 C 74 71 69 68 58 62 64 82 89 84 82 80 70 72 73 99 nil
6 C 80 59 61 51 66 73 67 78 93 70 76 66 84 88 84 95 nil
7 C 70 64 48 54 72 73 77 67 80 75 61 63 80 82 86 78 nil
8 C 70 65 71 71 85 94 84 80 83 77 81 81 105 104 95 95 nil
9 C 80 90 101 80 97 104 104 93 96 106 112 89 109 117 118 106 nil
10 C 70 72 67 66 87 87 89 77 93 98 88 80 97 104 104 92 nil
11 C 84 84 85 69 100 87 98 67 96 96 98 82 111 103 111 80 A-0.6mg(once)
12 C 80 80 84 63 90 92 88 82 96 96 104 80 110 111 101 95 nil
13 C 70 60 56 48 66 66 74 90 80 73 67 60 81 78 85 98 nil
14 C 70 63 48 55 54 75 76 72 83 78 62 66 68 86 88 86 A-0.6mg(once)
15 C 80 71 94 53 87 77 77 78 93 80 109 63 97 87 87 90 nil
16 C 90 85 89 74 12 91 81 80 103 96 99 87 114 103 93 93 nil
17 C 75 73 73 64 80 81 84 83 90 88 87 74 94 93 92 94 nil
18 C 90 77 93 83 76 76 76 62 107 88 110 94 89 89 85 75 nil
19 C 82 67 85 79 81 78 84 77 93 83 98 92 96 92 101 94 nil
20 C 70 63 64 46 78 75 69 75 86 73 74 56 85 86 80 90  E-6mg( once)
21 C 90 86 67 60 94 82 85 90 103 102 88 71 115 110 96 110 nil
22 C 80 73 75 64 85 72 72 78 93 85 87 76 96 83 82 91 nil
23 C 80 64 81 81 83 79 85 74 93 77 92 92 96 91 99 85 nil
24 C 80 72 62 65 103 101 97 82 93 85 72 75 119 115 111 92 nil
25 C 90 90 86 73 70 68 72 86 105 110 104 84 83 81 84 104 nil  
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